Trials / Completed
CompletedNCT00092144
Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Clinical Effect of Oral MK0476 Vs Placebo During the Allergy Season in Patients With Seasonal Aeroallergen Sensitivity and Chronic Asthma Which is Also Active During Allergy Season
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and safety of an approved drug on asthma symptoms in patients with chronic asthma which is also active during the allergy season.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0476, montelukast sodium / Duration of Treatment: 4 weeks | |
| DRUG | Comparator: placebo / Duration of Treatment: 4 weeks |
Timeline
- Start date
- 2004-02-26
- Primary completion
- 2004-06-15
- Completion
- 2004-06-15
- First posted
- 2004-09-24
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00092144. Inclusion in this directory is not an endorsement.